PGE-1 in replantation and free tissue transfer: Early preliminary experience

Microsurgery

Volumn 27, Issue 5, 2007, Pages 395-397

  Vegas, José Manuel Rodríguez ^a   Alonso, María Elena Ruiz ^b   Saavedra, Pedro Pablo Terán ^b  

^a Fundacion Jimenez Diaz Clinica Nuestra Senora de la Concepcion   (Spain)

^b HOSPITAL UNIVERSITARIO DE BURGOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PROSTAGLANDIN E1;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DRUG EFFECT; DRUG EFFICACY; ERYTHEMA; FEMALE; FREE TISSUE GRAFT; HUMAN; INJECTION SITE EDEMA; INJECTION SITE PAIN; LIMB REPLANTATION; MALE; MICROVASCULAR SURGERY; OUTCOME ASSESSMENT; PERFORATOR FLAP; PEROPERATIVE CARE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROTECTION; THROMBOSIS; THROMBOSIS PREVENTION;

ADOLESCENT; ADULT; AGED; ALPROSTADIL; AMPUTATION, TRAUMATIC; CHILD; FEMALE; FIBRINOLYTIC AGENTS; FINGER INJURIES; FINGERS; HAND INJURIES; HUMANS; MALE; MIDDLE AGED; REPLANTATION; SURGICAL FLAPS; THUMB;

EID: 34547874293     PISSN: 07381085     EISSN: 10982752     Source Type: Journal    
DOI: 10.1002/micr.20377     Document Type: Article

References (14)

1. Khouri RK, Cooley BC, Kunselman AR, Landis JR, Yeramian P, Ingram D, Natarajan N, Benes CO, Wallemark C. A prospective study of microvascular free-flap surgery and outcome. Plast Reconstr Surg 1998;102(3):711-721.
2. Salemark L. International survey of current microvascular practices in free tissue transfer and replantation surgery. Microsurgery 1991;12:308-311.
3. Glicksman A, Ferder M, Casale P, Posner J, Kim R, Strauch B. 1457 years of microsurgical experience. Plast Reconstr Surg 1997; 100(2):355-363.
4. Conrad MH, Adams WP. Pharmacologic optimization of microsurgery in the new millenium. Plast Reconstr Surg 2001;108:2088-2096.
5. Creutzig A, Lehmacher W, Elze M. Meta-analysis of randomized controlled prostaglandin E1 studies in peripheral arterial occlusive disease stages III and IV. Vasa 2004;33:137-144.
6. Diehm C, Balzer K, Bisler H, Bulling B, Camci M, Creutzig A, Gross JD, Horsch S, Odemar F, Piehler U, Rogatti W, Scheffler P, Spengel F, Treese N, Turowski A, Waldhausen P, Weber B, Weiss T. Efficacy of a new prostaglandin E1 regimen in outpatients with severe intermittent claudication: Results of a multicenter placebo-controlled double-blind trial. J Vasc Surg 1997;25:537-544.
7. Mangiafico RA, Messina R, Attina T, Dell'Arte S, Giuliano L, Malatino LS. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication. Angiology 2000;51:441-449.
8. Belcaro G, Nicolaides AN, Cipollone G, Laurora G, Incandela L, Cazaubon M, Barsotti A, Ledda A, Errichi BM, Cornelli U, Dugall M, Corsi M, Mezzanotte L, Geroulakos G, Fisher C, Szendro G, Simeone E, Cesarone MR, Bucci M, Agus G, De Sanctis MT, Ricci A, Ippolito E, Vasdekis S, Christopoulos D, Helmis H. The ORACL.E study group (european study). Nomograms used to define the short-term treatment with PGE1 in patients with intermittent claudication and critical ischemia. Angiology 2000;51: S3-13; discussion S14.
9. Mohrland JS, Porter JM, Smith EA, Belch J, Simms MH. A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome. Ann Rheum Dis 1985;44:754-760.
10. Pardy BJ, Hoare MC, Eastcott HH, Miles CC, Needham TN, Harbourne T, Ellis BW. Prostaglandin E1 in severe Raynaud's phenomenon. Surgery 1982;92:953-965.
11. Hong JP, Chung YK, Chung SH. The effect of prostaglandin E1 versus ischemia-reperfusion injury of musculocutaneous flaps. Ann Plast Surg 2001;47:316-321.
12. Schror K, Hohlfeld T. Mechanisms of anti-ischemic action of prostaglandin E1 in peripheral arterial occlusive disease. Vasa 2004;33:119-124.
13. Isogai N, Miyasato Y, Asamura S. Prostacyclin analogue (beraprost) relief of cold intolerance after digital replantation and revascularization. J Hand Surg B 2004;29:406-408.
14. Owada A, Saito H, Nagai T, Iwamoto H, Shigai T. Prophylactic use of intravenous prostaglandin E1 for radial arterial spasm in uremic patients undergoing construction of arteriovenous hemodialysis fistulas. Int J Artif Organs 1994;17:511-514.